Details

List of Contributors, viii <p>Foreword, xii</p> <p><b>Part 1 General Introduction</b></p> <p>1 Introduction, 3<br /> <i>Ren´e R.P. de Vries</i></p> <p>2 Hemovigilance: A Quality Tool for the Blood Transfusion Chain, 5<br /> <i>Ren´e R.P. de Vries</i></p> <p>3 Concepts and Models, 12<br /> <i>Ren´e R.P. de Vries and Jean-Claude Faber</i></p> <p><b>Part 2 Hemovigilance of the Blood Transfusion Chain (Blood Establishment and Hospital)</b></p> <p>Section 2.1: Setting up a Hemovigilance System</p> <p>4 Setting Up or Consolidating a System for Donor Hemovigilance at the Level of a Blood Establishment, 21<br /> <i>Johanna Wiersum-Osselton, Wim de Kort, Tanneke Marijt-van der Kreek, and Jeroen de Wit</i></p> <p>5 Preparation of Blood Components, 36<br /> <i>Tomislav Vuk</i></p> <p>6 Establishment of Hemovigilance for the Testing, Storage, Distribution, Transport, and Issuing of Blood and Blood Components: The Example of Greece, 52<br /> <i>Constantina Politis</i></p> <p>7 Medical Decision, Ordering, Administration of Component, and Monitoring of the Patient, 61<br /> <i>Mickey B.C. Koh, Ramir Alcantara, Mark Grumbridge, and Ai Leen Ang</i></p> <p>Section 2.2: How the System Works</p> <p>8 Blood Donation: An Approach to Donor Vigilance, 77<br /> <i>Peter Tomasulo, Madhav Erraguntla, and Hany Kamel</i></p> <p>9 Preparation of Blood Components, 99<br /> <i>Erhard Seifried, Reinhard Henschler, Juergen Luhm, Thea Mueller-Kuller, Hans-Ulrich Pfeiffer, Walid Sireis, and Markus M. Mueller</i></p> <p>10 Testing, Issuing, and Transport of Blood Components, 113<br /> <i>Constantina Politis</i></p> <p>11 Clinical Activities: Medical Decision-making, Sampling, Ordering Components, Administration, and Patient Monitoring, 126<br /> <i>Clare Taylor</i></p> <p><b>Part 3 National or Regional Hemovigilance Systems</b></p> <p>12 The French Hemovigilance Network: From the Blood Scandal to Epidemiologic Surveillance of the Transfusion Chain, 147<br /> <i>Philippe Renaudier</i></p> <p>13 The Japanese Hemovigilance System, 159<br /> <i>Hitoshi Okazaki, Naoko Goto, Shun-ya Momose, Satoru Hino, and Kenji Tadokoro</i></p> <p>14 Setting up a National Hemovigilance System: SHOT, 168<br /> <i>Hannah Cohen and Lorna M. Williamson</i></p> <p>15 The Dutch Hemovigilance System: Transfusion Reactions in Patients (TRIP), 180<br /> <i>Martin R. Schipperus, Johanna Wiersum-Osselton, Pauline Y. Zijlker-Jansen, and Anita J.W. van Tilborgh-de Jong</i></p> <p>16 Regulatory, Public Health, and International Aspects of Hemovigilance in Canada, 191<br /> <i>Peter R. Ganz and Jun Wu</i></p> <p>17 Setting up and Implementation of the National Hemovigilance System in Italy, 204<br /> <i>Giuliano Grazzini and Simonetta Pupella</i></p> <p>18 The Australian Hemovigilance System, 209<br /> <i>Erica M. Wood, Lisa J. Stevenson, Simon A. Brown, and Christopher J. Hogan</i></p> <p>19 Biovigilance in the United States, 220<br /> <i>D. Michael Strong, Barbee Whitaker, Matthew J. Kuehnert, and Jerry A. Holmberg</i></p> <p>20 Arab Hemovigilance Network, 226<br /> <i>Salwa Hindawi, Magdy Elekiaby, and Gamal Gabra</i></p> <p><b>Part 4 Hemovigilance at the International Level</b></p> <p>21 Hemovigilance in the European Community, 235<br /> <i>Jean-Claude Faber</i></p> <p>22 International collaboration, 253<br /> <i>Paul F.W. Strengers</i></p> <p>23 Hemovigilance in Developing Countries, 260<br /> <i>Jean-Claude Faber</i></p> <p><b>Part 5 Achievements</b></p> <p>24 Achievements Through Hemovigilance, 281<br /> <i>Jean-Claude Faber and F´atima Nascimento</i></p> <p><b>Part 6 Developments</b></p> <p>25 Vigilance of Alternatives for Blood Components, 305<br /> <i>Dafydd Thomas</i></p> <p>26 Surveillance of Clinical Effectiveness of Transfusion, 322<br /> <i>Brian McClelland and Katherine Forrester</i></p> <p>27 Biovigilance, 326<br /> <i>Jerry A. Holmberg, Matthew J. Kuehnert, and D. Michael Strong</i></p> <p>Appendices</p> <p>Appendix A Glossary, 343</p> <p>Appendix B Proposed standard definitions for surveillance of non infectious adverse transfusion reactions, 351</p> <p>Appendix C Standard for surveillance of complications related to blood donation, 360</p> <p>Index, 369</p>

<p>“This is a thoroughly fascinating read and will make you eager to implement or enhance your current hemovigilance efforts. I recommend it.”  (<i>Doody’s</i>, 26 April 2013)</p> <p> </p>

<p><strong>Professor René R.P. De Vries</strong>, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands and President of the European Haemovigilance Network. <p><strong>Dr Jean Claude Faber</strong>, Director of the Blood Transfusion Service, Luxembourg Red Cross, Luxembourg.<br />The editors are experts in the field of haemovigilance. Both are members of the Board of the International Haemovigilance Network (IHN) and of the International Society of Blood Transfusion (ISBT) Working Party on Haemovigilance.

GB